The role of PPAR-γ in the regulation of intestinal barrier during CDI was explored for the first time in the present study, in contrast to investigation of the anti-inflammatory effects of PPAR-γ on the gut in previous studies. This evidence concerns the gene PPARG and clostridium difficile infection.